Aktis Oncology Inc (AKTS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Aktis Oncology Inc   (NASDAQ: AKTS)
    Sector • Technology    Industry • Consumer Electronics
   Industry • Consumer Electronics
   Sector • Technology

Aktis Oncology Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKTS Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 43.88 % 57.71 % 46.06 %
Gross Margin (Q2 TTM) 33.41 % 49.24 % 57.27 % 46.3 %
Gross Profit Margin 5 Yr. Avg. --26.85 % 45.43 % 52.8 % 47.07 %
EBITDA Margin (Q2 MRQ) 56.5 % 24.11 % 39.09 % 20.57 %
EBITDA Margin (Q2 TTM) -114.15 % 25.97 % 34.62 % 19.07 %
EBITDA Margin 5 Yr. Avg. --573.49 % 18.76 % 27.15 % 22.06 %
Operating Margin (Q2 MRQ) -853.99 % 16.14 % 28.72 % 16.03 %
Operating Margin (Q2 TTM) -939.13 % 19.26 % 27.16 % 16.33 %
Operating Margin 5 Yr. Avg. --691.01 % 14.13 % 21.17 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 16.68 % 33.68 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -189.72 % 19.29 % 29.17 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.77 % 20.77 % 12.49 %
Net Margin (Q2 MRQ) -713.48 % 40.85 % 29.04 % 11.41 %
Net Margin (Q2 TTM) -781.95 % 15.79 % 24.33 % 10.76 %
Net Margin 5 Yr. Avg. - 10.94 % 17.56 % 9.95 %



Business Segment Profit Margin